• Sales -9% vs. ABGSCe, EBIT SEK 13m vs. ABGSCe 17m
  • Organic growth of 18%, strong gross margin 60% (57% LY)
  • We estimate opex includes ~SEK 2m for acquired and licensed tech

Q3 results

Sales came in at SEK 49m (-9% vs. ABGSCe 54m), +19% y-o-y (+18% org.). Growth was driven by the continued recovery at the second-largest customer and growth among smaller customers. The gross margin was 60% (57% LY), as the raw-material cost increases flagged earlier in the year have not materialised. EBIT was SEK 13m (vs. ABGSCe 17m), for a margin of +27% (ABGSCe +31%). Other external costs included the expensed purchase price for a newly acquired technology and the full annual minimum licence fee for a licensed technology. The amounts are not disclosed, but we estimate them at roughly SEK 2m in total based on the step-up vs. the H1 run rate.

Estimates and outlook

On numbers alone '26e-'28e sales and adj. EBIT change by -2%. On the EU process, member states are voting on the Commission’s proposal by written procedure between 7 and 21 October, and I-Tech says it has prepared to legally challenge a negative decision.

Valuation

The share has returned +10% L3M (vs. peer median +11% and OMXSSMAC -9%), and is currently trading at 14x-8x '26e-'28e P/E on our pre-report estimates vs. the peer median of 32x-16x. The company will host a presentation of the Q3 results at 13:00 CET.

Läs mer på ABG Sundal Collier

Läsaren av innehållet kan anta att ABG Sundal Collier har erhållit eller kommer att erhålla betalning för utförandet av finansiella företagstjänster från bolaget. Ersättningen är på förhand avtalad och är inte beroende av innehållet.

Ämnen i artikeln

I-tech

Senast

65,00

1 dag %

−10,22%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån